BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8286953)

  • 1. Purification of glutamine transaminase K/cysteine conjugate beta-lyase from rat renal cytosol based on hydrophobic interaction HPLC and gel permeation FPLC.
    Yamauchi A; Stijntjes GJ; Commandeur JN; Vermeulen NP
    Protein Expr Purif; 1993 Dec; 4(6):552-62. PubMed ID: 8286953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivation of selenocysteine Se-conjugates by a highly purified rat renal cysteine conjugate beta-lyase/glutamine transaminase K.
    Commandeur JN; Andreadou I; Rooseboom M; Out M; de Leur LJ; Groot E; Vermeulen NP
    J Pharmacol Exp Ther; 2000 Aug; 294(2):753-61. PubMed ID: 10900257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-ketoacids stimulate rat renal cysteine conjugate beta-lyase activity and potentiate the cytotoxicity of S-(1,2-dichlorovinyl)-L-cysteine.
    Elfarra AA; Lash LH; Anders MW
    Mol Pharmacol; 1987 Feb; 31(2):208-12. PubMed ID: 3807895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of human kidney cytosolic cysteine conjugate beta-lyase activity.
    Lash LH; Nelson RM; Van Dyke RA; Anders MW
    Drug Metab Dispos; 1990; 18(1):50-4. PubMed ID: 2139845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamine transaminase K is not a major cysteine S-conjugate beta-lyase of rat kidney mitochondria: evidence that a high-molecular weight enzyme fulfills this role.
    Abraham DG; Thomas RJ; Cooper AJ
    Mol Pharmacol; 1995 Nov; 48(5):855-60. PubMed ID: 7476916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and expression of a rat kidney cytosolic glutamine transaminase K that has strong sequence homology to kynurenine pyruvate aminotransferase.
    Abraham DG; Cooper AJ
    Arch Biochem Biophys; 1996 Nov; 335(2):311-20. PubMed ID: 8914928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling and molecular dynamics of glutamine transaminase K/cysteine conjugate beta-lyase.
    Venhorst J; ter Laak AM; Meijer M; van de Wetering I; Commandeur JN; Rooseboom M; Vermeulen NP
    J Mol Graph Model; 2003 Sep; 22(1):55-70. PubMed ID: 12798391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A purified cysteine conjugate beta-lyase from rat kidney cytosol. Requirement for an alpha-keto acid or an amino acid oxidase for activity and identity with soluble glutamine transaminase K.
    Stevens JL; Robbins JD; Byrd RA
    J Biol Chem; 1986 Nov; 261(33):15529-37. PubMed ID: 3782077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminotransferase, L-amino acid oxidase and beta-lyase reactions involving L-cysteine S-conjugates found in allium extracts. Relevance to biological activity?
    Cooper AJ; Pinto JT
    Biochem Pharmacol; 2005 Jan; 69(2):209-20. PubMed ID: 15627473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and expression of a cDNA coding for rat kidney cytosolic cysteine conjugate beta-lyase.
    Perry SJ; Schofield MA; MacFarlane M; Lock EA; King LJ; Gibson GG; Goldfarb PS
    Mol Pharmacol; 1993 May; 43(5):660-5. PubMed ID: 8502223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamine transaminase K and cysteine S-conjugate beta-lyase activity stains.
    Abraham DG; Cooper AJ
    Anal Biochem; 1991 Sep; 197(2):421-7. PubMed ID: 1723851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mitochondrial matrix enzymes in the metabolism and toxicity of cysteine conjugates.
    Stevens JL; Ayoubi N; Robbins JD
    J Biol Chem; 1988 Mar; 263(7):3395-401. PubMed ID: 3343250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cysteine S-conjugate beta-lyase in the metabolism of cisplatin.
    Zhang L; Hanigan MH
    J Pharmacol Exp Ther; 2003 Sep; 306(3):988-94. PubMed ID: 12750429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
    Lash LH; Sausen PJ; Duescher RJ; Cooley AJ; Elfarra AA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):374-83. PubMed ID: 8169843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants.
    Cooper AJ
    Neurochem Int; 2004 Jun; 44(8):557-77. PubMed ID: 15016471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of multiple pathways for the metabolism of nephrotoxic cysteine conjugates using selective inhibitors of L-alpha-hydroxy acid oxidase (L-amino acid oxidase) and cysteine conjugate beta-lyase.
    Stevens JL; Hatzinger PB; Hayden PJ
    Drug Metab Dispos; 1989; 17(3):297-303. PubMed ID: 2568912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine conjugate beta-lyase of rat kidney cytosol: characterization, immunocytochemical localization, and correlation with hexachlorobutadiene nephrotoxicity.
    MacFarlane M; Foster JR; Gibson GG; King LJ; Lock EA
    Toxicol Appl Pharmacol; 1989 Apr; 98(2):185-97. PubMed ID: 2711386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A).
    Iyer RA; Anders MW
    Chem Res Toxicol; 1997 Jul; 10(7):811-9. PubMed ID: 9250416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteine S-conjugates may act as kidney-selective prodrugs: formation of 6-mercaptopurine by the renal metabolism of S-(6-purinyl)-L-cysteine.
    Hwang IY; Elfarra AA
    J Pharmacol Exp Ther; 1989 Nov; 251(2):448-54. PubMed ID: 2810108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivation mechanism of cytotoxic homocysteine S-conjugates.
    Lash LH; Elfarra AA; Rakiewicz-Nemeth D; Anders MW
    Arch Biochem Biophys; 1990 Feb; 276(2):322-30. PubMed ID: 2154944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.